---
title: "TKRT released its 2024 annual performance, with a net profit attributable to the parent company of 214 million yuan, a year-on-year decrease of 26.26%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/233625816.md"
description: "TKRT released its 2024 annual performance, with operating revenue of 1.41 billion yuan, a year-on-year decrease of 13.91%; net profit attributable to shareholders of the parent company was 214 million yuan, a year-on-year decrease of 26.26%; net profit excluding non-recurring gains and losses was 211 million yuan, a year-on-year decrease of 26.72%; basic earnings per share were 1.02 yuan/share. The company plans to distribute a cash dividend of 3.50 yuan (tax included) for every 10 shares"
datetime: "2025-03-28T11:43:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/233625816.md)
  - [en](https://longbridge.com/en/news/233625816.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/233625816.md)
generator: "portal-rs"
---

# TKRT released its 2024 annual performance, with a net profit attributable to the parent company of 214 million yuan, a year-on-year decrease of 26.26%

According to the Zhitong Finance APP, TKRT (688569.SH) released its annual report for 2024, reporting an operating income of 1.41 billion yuan, a year-on-year decrease of 13.91%; net profit attributable to shareholders of the listed company was 214 million yuan, a year-on-year decrease of 26.26%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 211 million yuan, a year-on-year decrease of 26.72%; basic earnings per share were 1.02 yuan/share. It plans to distribute a cash dividend of 3.50 yuan (including tax) for every 10 shares

### Related Stocks

- [688569.CN](https://longbridge.com/en/quote/688569.CN.md)

## Related News & Research

- [2024 Lamborghini Revuelto listed at $200K, far below market value](https://longbridge.com/en/news/296401601.md)
- [Rossi Residencial files delayed 2025 financial statements after late 2024 accounts release](https://longbridge.com/en/news/296291749.md)
- [REG - Aberdeen Asian Inc - Director/PDMR Shareholding](https://longbridge.com/en/news/296505605.md)
- ["July Was A Bad Month": Jane Street Lost $15 Billion In First Down Month In A Decade](https://longbridge.com/en/news/296131995.md)
- [Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate](https://longbridge.com/en/news/296689195.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**